VX-710 blocker of the p-glycoprotein pump that ejects chemotherapeutics from cancer cells: Began a Phase I dose escalation trial in 45 patients receiving paclit

Vertex Pharmaceuticals Inc. (VRTX), Cambridge, Mass. Product: VX-710 blocker of the p-glycoprotein pump that ejects chemotherapeutics from cancer cells Indication: Reverse multiple drug resistance in ...